Jeffrey M. Leiden is CEO & President at VERTEX PHARMACEUTICALS INC / MA (VRTX). They have made 42 open-market trades across 4 companies since 2006, most recently 2026-05-11.
CIK 0001242825
3 open-market purchases totalling $200K since 2010, against 39 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ABT | 209,401 | $22.0M |
| VRTX | 34,797 | $17.4M |
| DGX | 6,000 | $1.4M |
| ODTX | 31,644 | $545K |
| Total | $41.3M |
Shares reported on the most recent Form 4, priced at the 2026-05-11 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ODTX | BUY | 2026-05-08 | 2026-05-11 | $20.00 | $100K | +2.8% | -7.3% | +28.1% |
| VRTX | SELL · 10b5-1 | 2025-12-03 | 2025-12-05 | $449.20 | $57.3M | -1.3% | -1.5% | +1.1% |
| VRTX | SELL · 10b5-1 | 2025-11-13 | 2025-11-17 | $440.59 | $64.1M | -0.1% | +3.6% | +10.0% |
| VRTX | SELL · 10b5-1 | 2024-08-30 | 2024-09-04 | $499.00 | $1.9M | +2.4% | -4.7% | -4.3% |
| VRTX | SELL · 10b5-1 | 2024-02-14 | 2024-02-16 | $419.10 | $7.6M | -0.0% | -2.2% | +4.7% |
| VRTX | SELL · 10b5-1 | 2024-02-12 | 2024-02-14 | $419.42 | $2.8M | +2.8% | -2.7% | +2.2% |
| VRTX | SELL · 10b5-1 | 2024-01-08 | 2024-01-10 | $419.07 | $5.6M | +4.0% | +0.0% | -4.3% |
| VRTX | SELL · 10b5-1 | 2023-12-13 | 2023-12-15 | $399.41 | $10.6M | -0.6% | +6.3% | -0.7% |
| VRTX | SELL · 10b5-1 | 2023-10-16 | 2023-10-18 | $374.00 | $4.8M | -2.7% | -4.6% | +19.0% |
| VRTX | SELL · 10b5-1 | 2023-05-05 | 2023-05-09 | $349.34 | $1.0M | -1.8% | -4.4% | -0.8% |
| VRTX | SELL · 10b5-1 | 2023-05-02 | 2023-05-04 | $349.88 | $6.9M | -0.5% | -3.6% | +3.3% |
| VRTX | SELL | 2022-07-25 | 2022-07-27 | $281.38 | $74.3M | +2.2% | -2.0% | +7.5% |
| VRTX | SELL | 2022-04-13 | 2022-04-14 | $289.04 | $9.1M | -7.1% | -11.6% | +0.4% |
| VRTX | SELL | 2020-06-30 | 2020-07-02 | $286.12 | $18.6M | +0.3% | -5.0% | -7.6% |
| VRTX | SELL | 2020-05-12 | 2020-05-14 | $283.47 | $53.5M | +1.0% | -2.9% | -1.7% |
| VRTX | SELL | 2020-05-07 | 2020-05-08 | $269.78 | $50.9M | +4.9% | -2.4% | +0.7% |
| VRTX | SELL | 2020-05-05 | 2020-05-07 | $269.94 | $51.0M | +4.7% | -1.7% | +1.4% |
| VRTX | SELL | 2020-02-25 | 2020-02-26 | $233.74 | $4.4M | -3.9% | -4.9% | +16.6% |
| VRTX | SELL | 2020-02-18 | 2020-02-19 | $243.52 | $5.7M | -6.1% | -16.7% | +14.1% |
| VRTX | SELL | 2020-02-11 | 2020-02-12 | $246.17 | $22.7M | -4.7% | -8.5% | +14.5% |
| VRTX | SELL | 2019-11-19 | 2019-11-21 | $210.91 | $20.4M | +3.2% | +1.4% | +14.2% |
| VRTX | SELL | 2019-11-19 | 2019-11-21 | $210.91 | $20.4M | +3.2% | +1.4% | +14.2% |
| VRTX | SELL | 2019-11-15 | 2019-11-19 | $210.00 | $2.0M | +2.8% | +1.4% | +14.5% |
| VRTX | SELL | 2019-11-01 | 2019-11-04 | $200.06 | $5.3M | +3.0% | +12.5% | +15.8% |
| VRTX | SELL | 2019-10-31 | 2019-11-04 | $200.02 | $21.1M | +3.0% | +12.5% | +15.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.